Home Cart Sign in  
Chemical Structure| 70356-03-5 Chemical Structure| 70356-03-5

Structure of Cefaclor monohydrate
CAS No.: 70356-03-5

Chemical Structure| 70356-03-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cefaclor Monohydrate is a second-generation cephalosporin antibiotic used to treat certain bacterial infections

Synonyms: Cefaclor; Cefaclorum; Cefaclor(monohydrate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cefaclor monohydrate

CAS No. :70356-03-5
Formula : C15H16ClN3O5S
M.W : 385.82
SMILES Code : O=C(C(N12)=C(Cl)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=CC=C3)=O)C1=O)O.[H]O[H]
Synonyms :
Cefaclor; Cefaclorum; Cefaclor(monohydrate)
InChI Key :WKJGTOYAEQDNIA-IOOZKYRYSA-N
Pubchem ID :51038

Safety of Cefaclor monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

Description
Cefaclor is an orally active cephalosporin antibiotic that is well absorbed. It specifically targets penicillin-binding protein 3 (PBP3) and is used for the treatment and research of various bacterial infections such as respiratory tract infections, bacterial bronchitis, pharyngitis, and skin infections. It also has potential implications for studying depression[1].[2].[3].[4].

In Vitro:

Cell Line
Concentration Treated Time Description References
Haemophilus parasuis clinical strain C7 0.015625 - 256 μg/mL 24-48 h To screen for cefaclor-resistant strains and determine their resistance mechanisms. Front Microbiol. 2024 Mar 15;15:1364339
STC-1 cells 1–20 mM Cefaclor stimulates CCK release from STC-1 cells, involving pertussis toxin-sensitive G protein(s) and Ca2+ availability. Br J Pharmacol. 2000 Oct;131(3):399-404

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Anxiety- and depression-like behavior model Oral 200 mg/kg Once a day for 5 days To investigate the effect of cefaclor on anxiety- and depression-like behaviors in mice. Results showed that cefaclor induced anxiety- and depression-like behaviors and altered gut microbiota and neurotransmitter levels. Sci Rep. 2023 Sep 19;13(1):15529
Sprague-Dawley rats Delayed gastric emptying model Intragastric instillation 3, 10, 30, 100 μM Single dose, measured 5 minutes after administration Cefaclor delays gastric emptying via a CCK-A receptor-mediated mechanism, and this effect is reversed by the CCK-A antagonist SR-27897B. Additionally, cefaclor acts through capsaicin-sensitive afferent pathways. Br J Pharmacol. 2000 Oct;131(3):399-404

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.96mL

2.59mL

1.30mL

25.92mL

5.18mL

2.59mL

References

 

Historical Records

Categories